EYY-16190-23531
3 vaccinations
5 coded responses
34 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 770 / TX
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
- 2020-12-17
-
2020-12-18
Survey response — days 1–6 daily, dose 1MedDRA: Pain in extremity, Vaccine positive rechallenge — Feeling: GoodFree text: There is mild soreness around the injection site like there is with the flu shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
- 2021-01-08
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy, Pain — Feeling: Fair · DiarrheaFree text: Enlarged supraclavicular lymph node on the injection side. Moderately painful to palpation. Mildly painful with AROM of neck and right arm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · HeadacheFree text: Enlarged supraclavicular lymph node on the injection sideMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Size of previously reported supra clavicular lymph node is going down. Not painful.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
- 2021-01-29
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-10
- 2021-07-10
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-09
- 2021-10-14
- 2021-10-21
- 2021-11-04
- 2021-11-13
-
2021-12-30
Survey response — 3 months, dose 3MedDRA: Back pain, Chest pain, Dyspnoea, Fatigue, Office visit, Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Shortness of breathe, tachycardia at rest and with very minimal activity, chest pain, back pain, fatigue. Currently seeing several physicians to obtain a dx · Healthcare visit (other): Internal medicine, Cardiologist, Endocrinologist, and GynecologistMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): There is mild soreness around the injection site like there is with the flu shot
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Enlarged supraclavicular lymph node on the injection side. Moderately painful to palpation. Mildly painful with AROM of neck and right arm.
Systemic reaction (other): Enlarged supraclavicular lymph node on the injection side
Release 2 — day 7, dose 2
Systemic reaction (other): Size of previously reported supra clavicular lymph node is going down. Not painful.
Release 10 — 3 months, dose 3
Symptoms: Shortness of breathe, tachycardia at rest and with very minimal activity, chest pain, back pain, fatigue. Currently seeing several physicians to obtain a dx
Healthcare visit (other): Internal medicine, Cardiologist, Endocrinologist, and Gynecologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SRO | Injection site pain | ○ | ○ | ○ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Neck pain | ○ | ○ | ○ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Palpitations | ○ | ○ | ○ |
| SRO | Vaccine positive rechallenge | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release